-
MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care
This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body. Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery. Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…
You May Also Like
CXM Software Creator Just Uplisted Last Month — Here’s What You May Want To Know
Internet Marketing in Action: “The Sabir Bey Show” Season Premiere on October 1
NASA-Approved Technologies Essential to Creating Cooler, Lighter and Safer Batteries for EV, Aeronautics and Smart Device Technologies
-
Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest
Previously published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!” But given the state of our world at this moment, one startup really stood out. Its key product is the Bioflux and it’s considered the “smallest, most accurate device on the market.” Our Current Problem Heart disease is the leading cause of death in men and women every year in the United States.…
